Tag

Oral Treatment

All articles tagged with #oral treatment

Breakthrough: FDA Approves Oral Treatment for Postpartum Depression
health2 years ago

Breakthrough: FDA Approves Oral Treatment for Postpartum Depression

The FDA has approved Zurzuvae (zuranolone), the first oral medication for postpartum depression (PPD) in adults. PPD is a major depressive episode that occurs after childbirth or during late pregnancy. Previously, treatment for PPD was only available as an IV injection. Zurzuvae demonstrated efficacy in two studies, showing significant improvement in depressive symptoms compared to placebo. However, the medication carries a boxed warning regarding its impact on driving and other potentially hazardous activities. Common side effects include drowsiness, dizziness, diarrhea, fatigue, and urinary tract infection. Zurzuvae may cause fetal harm, and effective contraception is recommended while taking the medication.

FDA approves Rinvoq as first JAK inhibitor for Crohn's Disease.
healthcare2 years ago

FDA approves Rinvoq as first JAK inhibitor for Crohn's Disease.

FDA has approved Rinvoq (upadacitinib) as the first oral treatment for adults with moderately to severely active Crohn’s disease who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers. Rinvoq is a Janus kinase (JAK) inhibitor and should not be used in combination with other JAK inhibitors, biological therapies for Crohn’s disease, or with strong immunosuppressants such as azathioprine and cyclosporine. The most common side effects of Rinvoq are upper respiratory tract infections, anemia, fever, acne, herpes zoster, and headache.